Dr. Alberto Siccardi, born around 1944, is the founder and patriarch of the medical device giant Medacta International, based in Switzerland. His life's work is rooted in a generational family commitment to patient care: his father, Dr. Francesco Siccardi Sr., founded 'Bieffe Biochimici' in Florence in 1958, a company specializing in dialysis and medical fluids.

Alberto received a rigorous scientific and business education, earning a degree in Pharmacy from the University of Turin (1969) and an MBA with distinction from SDA Bocconi School of Management in Milan (1979). The single greatest catalyst for his career pivot, however, was personal experience: in the early 1990s, he suffered a bad fall in the Swiss Alps, leading to a double hip replacement. Dissatisfied with the quality and process of the surgery, he was driven to fundamentally improve orthopedic care.

Alberto Siccardi spent his early career successfully developing and expanding the family company, 'Bieffe Medital SPA', internationally through the innovative use of new technology for sterile fluids. The first major financial milestone came in 1997 when the family sold a unit of that business to Baxter Group for $185 million.

Using these proceeds and fueled by his passion to create a better patient experience following his own surgery, Siccardi founded Medacta International in 1999. He served as CEO for nearly two decades, pioneering a model centered on Minimally Invasive Surgery (AMIS) and intensive surgeon education (M.O.R.E. Institute). The culmination of his work was Medacta’s successful IPO on the SIX Swiss Exchange in 2019, which valued the company at over $2 billion and secured the family’s wealth. He stepped down as CEO in 2018, passing the operational reins to his son, Francesco Siccardi, while remaining Founder and Chairman.

Alberto Siccardi's philanthropic impact is intensely focused on health and community well-being, channeled through the Medacta for Life Foundation. The foundation embodies the family’s core values: dedication to improving patient outcomes and commitment to the local community in Ticino, Switzerland.

• Medical Education: The foundation supports Medacta’s M.O.R.E. Institute, which trains surgeons globally on minimally invasive techniques, thereby improving care for patients worldwide.
• Community and Humanitarian Aid: The foundation actively supports local community care, including the My School Ticino Campus for children, and provides humanitarian initiatives internationally, such as donating surgical instruments to support the Ukrainian population afflicted by conflict.

Siccardi’s entire entrepreneurial mission, born from his own negative patient experience, is a unique form of 'patient-founded' social enterprise focused on reducing surgical costs and increasing 'healthcare sustainability'.